• Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT in Immunocompromised Patients with Recurrent cSCC | Morningstar

    来源: Buzz FX / 20 9月 2024 09:07:16   America/Chicago


    [GlobeNewswire](/news/globe-newswire) Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT in Immunocompromised Patients with Recurrent cSCC JERUSALEM, Sept.
    Read more...
分享